1. Home
  2. /
  3. Medications
  4. /
  5. Toray RAPROS®
Toray RAPROS®
RENAL MEDICATIONS Tomorrow's renal care today
Previously there has never been approved veterinary drugs that target CKD. The Japanese company, Toray, has been leading the innovation with the first approved veterinary drug on the market and more is sure to come.
Toray

Toray RAPROS®

0 SEK
  • First veterinary drug approved for the indication of “suppression of deterioration of renal function”.
  • RAPROS® improves anorexia in feline CKD. It also suppresses weight body loss and improve hypoactivity¹.
  • High safety confirmed in clinical trial.
Read more...
HIDDEN
0 in stock
Delivery within 2-4 business days*
Fast & reliable European delivery

Orders are processed the same day or the next business day and shipped from within Europe. Estimated delivery times are shown below:

Region Estimated delivery
Northern Europe 2-4 business days
Western Europe 2-4 business days
Southern Europe 3-5 business days
Eastern Europe 3-6 business days

Shipping costs are calculated at checkout based on your location and order size.

Once your order ships, you'll receive a tracking link by email so you can follow your delivery every step of the way.

For full delivery details, please refer to Shipping & Returns.

Return policy
Returns & Refunds

We want you to feel confident ordering from KidneyCo. Please review the main points of our return policy below.

30-Day Return Window
  • Returns are accepted within 30 days of delivery
  • Items must be unused, unopened, and in their original packaging
  • Inidividual cans may be returned only if unopened
Food Products
  • Due to the nature of pet food and feline dietary sensitivity, opened food, used products, or partially consumed items cannot be returned
  • We cannot offer refunds simply because a cat does not like a product

For full return refund details, please refer to our Return Refund Policy.

Your cat might also like Based on other users purchases
About this item
Description
  • First veterinary drug approved for the indication of “suppression of deterioration of renal function”.
  • RAPROS® improves anorexia in feline CKD. It also suppresses weight body loss and improve hypoactivity¹.
  • High safety confirmed in clinical trial.

Beraprost sodium, active substance of RAPROS®, suppresses deterioration of renal function by protecting vascular endothelial cells.

¹A Double-blind, Placebo-controlled, Multicenter, Prospective, Randomized Study of Beraprost Sodium Treatment for Cats with Chronic Kidney Disease

Specifications
No specifications provided.
Directions
Orally administer 1 tablet per cat, twice a day after feeding.
Ingredients
Each tablet contains 55μg of beraprost sodium.
Reviews This product has no reviews.